Kelly Kiser1, Kaylie D Webb-Jones2, Sara J Bowne3, Lori S Sullivan3, Stephen P Daiger4, David G Birch5. 1. Retina Foundation of the Southwest, Dallas, Texas, USA; UT Southwestern Medical Center, Dallas, Texas, USA. Electronic address: kkiser@rfsw.org. 2. Retina Foundation of the Southwest, Dallas, Texas, USA. 3. Human Genetics Center, School of Public Health, University of Texas Health Science Center Houston (UTHealth), Houston, Texas, USA. 4. Human Genetics Center, School of Public Health, University of Texas Health Science Center Houston (UTHealth), Houston, Texas, USA; Ruiz Department of Ophthalmology and Visual Science, McGovern Medical School, University of Texas Health Science Center Houston (UTHealth), Houston, Texas, USA. 5. Retina Foundation of the Southwest, Dallas, Texas, USA; UT Southwestern Medical Center, Dallas, Texas, USA.
Abstract
PURPOSE: Variants in PRPF31, a splicing factor, are a common cause of autosomal dominant retinitis pigmentosa (RP). Deleterious variants are thought to cause disease by haploinsufficiency. In anticipation of upcoming replacement gene therapy trials, we present the phenotype and clinical progression of a large cohort of patients with PRPF31-mediated RP. DESIGN: Cross-sectional with retrospective review. METHODS: A total of 26 patients with RP and 5 asymptomatic individuals, all with deleterious variants in PRPF31 (from 13 families), were selected from our database of patients followed longitudinally. Ages ranged from 9 to 77 years (mean 47 years), with an average follow-up time of 16 years. All patients underwent ophthalmic examination including psychophysical tests, electrophysiology, and imaging. All available records were reviewed retrospectively. Additionally, all patients were contacted, and all available patients (n = 7) were examined in an additional prospective follow-up visit. RESULTS: Age of onset ranged from 6 to 71 years, without apparent relationship to specific variant. Two adults (aged 42 and 77 years) and 3 teenaged children were found to harbor a mutation with no evidence of RP. In those with RP, visual field area (spot size III) declined exponentially at a rate of 8.1% per year of disease duration (P < .001, 95% confidence interval [CI] 5.6-10.6), cone electroretinogram amplitude declined exponentially at a rate of 7.3% per year of disease duration (P < .001, 95% CI 5.4-9.1), and ellipsoid zone area declined exponentially at a rate of 5.4% per year of disease duration (P < .001, 95% CI 3.7-7.1). CONCLUSIONS: PRPF31-mediated retinitis pigmentosa is characterized by a variable age of onset. Once disease develops, it follows a predictable exponential time course.
PURPOSE: Variants in PRPF31, a splicing factor, are a common cause of autosomal dominant retinitis pigmentosa (RP). Deleterious variants are thought to cause disease by haploinsufficiency. In anticipation of upcoming replacement gene therapy trials, we present the phenotype and clinical progression of a large cohort of patients with PRPF31-mediated RP. DESIGN: Cross-sectional with retrospective review. METHODS: A total of 26 patients with RP and 5 asymptomatic individuals, all with deleterious variants in PRPF31 (from 13 families), were selected from our database of patients followed longitudinally. Ages ranged from 9 to 77 years (mean 47 years), with an average follow-up time of 16 years. All patients underwent ophthalmic examination including psychophysical tests, electrophysiology, and imaging. All available records were reviewed retrospectively. Additionally, all patients were contacted, and all available patients (n = 7) were examined in an additional prospective follow-up visit. RESULTS: Age of onset ranged from 6 to 71 years, without apparent relationship to specific variant. Two adults (aged 42 and 77 years) and 3 teenaged children were found to harbor a mutation with no evidence of RP. In those with RP, visual field area (spot size III) declined exponentially at a rate of 8.1% per year of disease duration (P < .001, 95% confidence interval [CI] 5.6-10.6), cone electroretinogram amplitude declined exponentially at a rate of 7.3% per year of disease duration (P < .001, 95% CI 5.4-9.1), and ellipsoid zone area declined exponentially at a rate of 5.4% per year of disease duration (P < .001, 95% CI 3.7-7.1). CONCLUSIONS:PRPF31-mediated retinitis pigmentosa is characterized by a variable age of onset. Once disease develops, it follows a predictable exponential time course.
Authors: Cindy X Cai; Kirsten G Locke; Rithambara Ramachandran; David G Birch; Donald C Hood Journal: Invest Ophthalmol Vis Sci Date: 2014-10-23 Impact factor: 4.799
Authors: Caroline Van Cauwenbergh; Frauke Coppieters; Dimitri Roels; Sarah De Jaegere; Helena Flipts; Julie De Zaeytijd; Sophie Walraedt; Charlotte Claes; Erik Fransen; Guy Van Camp; Fanny Depasse; Ingele Casteels; Thomy de Ravel; Bart P Leroy; Elfride De Baere Journal: PLoS One Date: 2017-01-11 Impact factor: 3.240
Authors: David B McGuigan; Elise Heon; Artur V Cideciyan; Rinki Ratnapriya; Monica Lu; Alexander Sumaroka; Alejandro J Roman; Vaishnavi Batmanabane; Alexandra V Garafalo; Edwin M Stone; Anand Swaroop; Samuel G Jacobson Journal: Genes (Basel) Date: 2017-07-12 Impact factor: 4.096
Authors: Thiago Cabral; Jose Ronaldo Lima de Carvalho; Joonpyo Kim; Jin Kyun Oh; Sarah R Levi; Karen Sophia Park; Jimmy K Duong; Junhyung Park; Katherine Boudreault; Rubens Belfort; Stephen H Tsang Journal: Int J Mol Sci Date: 2020-04-15 Impact factor: 5.923
Authors: Tasneem A Arsiwalla; Elisa E Cornish; Phuc Vuong Nguyen; Maria Korsakova; Haipha Ali; Nonna Saakova; Clare L Fraser; Robyn V Jamieson; John R Grigg Journal: Transl Vis Sci Technol Date: 2020-12-17 Impact factor: 3.283
Authors: Samuel McLenachan; Dan Zhang; Janya Grainok; Xiao Zhang; Zhiqin Huang; Shang-Chih Chen; Khine Zaw; Alanis Lima; Luke Jennings; Danial Roshandel; Sang Yoon Moon; Rachael C Heath Jeffery; Mary S Attia; Jennifer A Thompson; Tina M Lamey; Terri L McLaren; John De Roach; Sue Fletcher; Fred K Chen Journal: Genes (Basel) Date: 2021-09-28 Impact factor: 4.096
Authors: Danial Roshandel; Jennifer A Thompson; Rachael C Heath Jeffery; Dan Zhang; Tina M Lamey; Terri L McLaren; John N De Roach; Samuel McLenachan; David A Mackey; Fred K Chen Journal: Genes (Basel) Date: 2021-06-14 Impact factor: 4.096